Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
1. (WO2005123731) PYRROLOPYRIDINE DERIVATIVES AND THEIR USE AS CRTH2 ANTAGONISTS
Latest bibliographic data on file with the International Bureau

Pub. No.: WO/2005/123731 International Application No.: PCT/EP2005/006493
Publication Date: 29.12.2005 International Filing Date: 16.06.2005
IPC:
C07D 471/04 (2006.01) ,A61K 31/437 (2006.01)
C CHEMISTRY; METALLURGY
07
ORGANIC CHEMISTRY
D
HETEROCYCLIC COMPOUNDS
471
Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/-C07D463/251
02
in which the condensed system contains two hetero rings
04
Ortho-condensed systems
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
33
Heterocyclic compounds
395
having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
435
having six-membered rings with one nitrogen as the only ring hetero atom
4353
ortho- or peri-condensed with heterocyclic ring systems
437
the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
Applicants:
NOVARTIS AG [CH/CH]; Lichtstrasse 35 CH-4056 Basel, CH (AE, AG, AL, AM, AU, AZ, BA, BB, BE, BF, BG, BJ, BR, BW, BY, BZ, CA, CF, CG, CH, CI, CM, CN, CO, CR, CU, CY, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, FR, GA, GB, GD, GE, GH, GM, GN, GQ, GR, GW, HR, HU, ID, IE, IL, IN, IS, IT, JP, KE, KG, KM, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MC, MD, MG, MK, ML, MN, MR, MW, MX, MZ, NA, NE, NG, NI, NL, NO, NZ, OM, PG, PH, PL, PT, RO, RU, SC, SD, SE, SG, SI, SK, SL, SM, SN, SY, SZ, TD, TG, TJ, TM, TN, TR, TT, TZ, UA, UG, UZ, VC, VN, YU, ZA, ZM, ZW)
NOVARTIS PHARMA GMBH [AT/AT]; Brunner Strasse 59 A-1230 Vienna, AT (AT)
BALA, Kamlesh [GB/GB]; GB (UsOnly)
LEBLANC, Catherine [FR/GB]; GB (UsOnly)
SANDHAM, David, Andrew [GB/GB]; GB (UsOnly)
TURNER, Katharine, Louise [GB/GB]; GB (UsOnly)
WATSON, Simon, James [GB/GB]; GB (UsOnly)
BROWN, Lyndon, Nigel [GB/GB]; GB (UsOnly)
COX, Brian [GB/GB]; GB (UsOnly)
Inventors:
BALA, Kamlesh; GB
LEBLANC, Catherine; GB
SANDHAM, David, Andrew; GB
TURNER, Katharine, Louise; GB
WATSON, Simon, James; GB
BROWN, Lyndon, Nigel; GB
COX, Brian; GB
Agent:
DE WEERD, Peter; Novartis AG Corporate Intellectual Property CH-4002 Basel, CH
Priority Data:
0413619.817.06.2004GB
0507693.015.04.2005GB
Title (EN) PYRROLOPYRIDINE DERIVATIVES AND THEIR USE AS CRTH2 ANTAGONISTS
(FR) COMPOSES ORGANIQUES
Abstract:
(EN) There are provided according to the invention compounds of formula (I), in free or salt form, wherein R1, R2, R3, R4, R5, R6, Q, W, X, m, n and p are as described in the specification, process for preparing them, and their use as pharmaceuticals.
(FR) L'invention concerne des composés, libres ou sous forme de sels, représentés par la formule (I), dans laquelle R1, R2, R3, R4, R5, R6, Q, W, X, m, n et p sont comme spécifiés dans le descriptif, le procédé de fabrication de ces composés et leur utilisation comme produits pharmaceutiques.
front page image
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, SM, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LT, LU, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)
Also published as:
DZDZP2007000024NO20070323RSP-2007/0507MXPA/a/2006/014694KR1020070032694ZA2006/09527
IL179604EP1761529JP2008502638RU02379309US20080114022CN101035786
CA2569125TN2006000410NZ551439AU2005254681DK1761529ID047.0375
IN7126/DELNP/2006BRPI0512060